Prior authorization leeway will be trimmed while health plans get more money under new federal rules for Medicare Advantage plans.

The FDA has accepted for review a resubmission of the BLA for bevacizumab-vikg (ONS-5010) for the treatment of wet AMD.

Australian and regional temperature timeseries are available from 1910 to present (prior to 1910 Australian temperature observations ... developed for monitoring climate variability and change in ...